173 related articles for article (PubMed ID: 19007293)
1. Identification of small molecular weight inhibitors of Src homology 2 domain-containing tyrosine phosphatase 2 (SHP-2) via in silico database screening combined with experimental assay.
Yu WM; Guvench O; Mackerell AD; Qu CK
J Med Chem; 2008 Dec; 51(23):7396-404. PubMed ID: 19007293
[TBL] [Abstract][Full Text] [Related]
2. Targeting protein tyrosine phosphatase SHP2 for the treatment of PTPN11-associated malignancies.
Yu B; Liu W; Yu WM; Loh ML; Alter S; Guvench O; Mackerell AD; Tang LD; Qu CK
Mol Cancer Ther; 2013 Sep; 12(9):1738-48. PubMed ID: 23825065
[TBL] [Abstract][Full Text] [Related]
3. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
Huang N; Nagarsekar A; Xia G; Hayashi J; MacKerell AD
J Med Chem; 2004 Jul; 47(14):3502-11. PubMed ID: 15214778
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor Binding Sites in the Protein Tyrosine Phosphatase SHP-2.
Zhang H; Gao Z; Meng C; Li X; Shi D
Mini Rev Med Chem; 2020; 20(11):1017-1030. PubMed ID: 32124695
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, biological activity and molecular dynamics studies of specific protein tyrosine phosphatase 1B inhibitors over SHP-2.
Sun SX; Li XB; Liu WB; Ma Y; Wang RL; Cheng XC; Wang SQ; Liu W
Int J Mol Sci; 2013 Jun; 14(6):12661-74. PubMed ID: 23774838
[TBL] [Abstract][Full Text] [Related]
6. Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11).
Liu W; Yu B; Xu G; Xu WR; Loh ML; Tang LD; Qu CK
J Med Chem; 2013 Sep; 56(18):7212-21. PubMed ID: 23957426
[TBL] [Abstract][Full Text] [Related]
7. A Ce(iii) complex potently inhibits the activity and expression of tyrosine phosphatase SHP-2.
Lin L; Lu L; Du R; Yuan C; Zhu M; Fu X; Xing S
Dalton Trans; 2019 Dec; 48(47):17673-17682. PubMed ID: 31763642
[TBL] [Abstract][Full Text] [Related]
8. Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2).
Zhang X; He Y; Liu S; Yu Z; Jiang ZX; Yang Z; Dong Y; Nabinger SC; Wu L; Gunawan AM; Wang L; Chan RJ; Zhang ZY
J Med Chem; 2010 Mar; 53(6):2482-93. PubMed ID: 20170098
[TBL] [Abstract][Full Text] [Related]
9. Chicken Ig-like receptor B2, a member of a multigene family, is mainly expressed on B lymphocytes, recruits both Src homology 2 domain containing protein tyrosine phosphatase (SHP)-1 and SHP-2, and inhibits proliferation.
Viertlboeck BC; Crooijmans RP; Groenen MA; Göbel TW
J Immunol; 2004 Dec; 173(12):7385-93. PubMed ID: 15585863
[TBL] [Abstract][Full Text] [Related]
10. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2.
Jackson DE; Kupcho KR; Newman PJ
J Biol Chem; 1997 Oct; 272(40):24868-75. PubMed ID: 9312087
[TBL] [Abstract][Full Text] [Related]
11. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.
Pathak MK; Yi T
J Immunol; 2001 Sep; 167(6):3391-7. PubMed ID: 11544330
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo.
Grosskopf S; Eckert C; Arkona C; Radetzki S; Böhm K; Heinemann U; Wolber G; von Kries JP; Birchmeier W; Rademann J
ChemMedChem; 2015 May; 10(5):815-26. PubMed ID: 25877780
[TBL] [Abstract][Full Text] [Related]
13. Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of SRC homology 2 domain-containing protein tyrosine phosphatase-2 activity.
Dawson MI; Xia Z; Jiang T; Ye M; Fontana JA; Farhana L; Patel B; Xue LP; Bhuiyan M; Pellicciari R; Macchiarulo A; Nuti R; Zhang XK; Han YH; Tautz L; Hobbs PD; Jong L; Waleh N; Chao WR; Feng GS; Pang Y; Su Y
J Med Chem; 2008 Sep; 51(18):5650-62. PubMed ID: 18759424
[TBL] [Abstract][Full Text] [Related]
14. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
15. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
Nakamura K; Brauweiler A; Cambier JC
J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
[TBL] [Abstract][Full Text] [Related]
16. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
Yusa S; Campbell KS
J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
[TBL] [Abstract][Full Text] [Related]
17. The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling.
Tibaldi E; Zonta F; Bordin L; Magrin E; Gringeri E; Cillo U; Idotta G; Pagano MA; Brunati AM
Biochim Biophys Acta; 2014 Feb; 1843(2):288-98. PubMed ID: 24140598
[TBL] [Abstract][Full Text] [Related]
18. Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates.
Hua CT; Gamble JR; Vadas MA; Jackson DE
J Biol Chem; 1998 Oct; 273(43):28332-40. PubMed ID: 9774457
[TBL] [Abstract][Full Text] [Related]
19. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
[TBL] [Abstract][Full Text] [Related]
20. Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells.
Tang H; Zhao ZJ; Huang XY; Landon EJ; Inagami T
J Biol Chem; 1999 Apr; 274(18):12401-7. PubMed ID: 10212213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
